Skip to main content

Walmart unveils low-price insulin as more patients with diabetes struggle to pay for drug

The nation's largest retailer is bringing its focus on "everyday low price" to a diabetes drug that has soared in cost and drawn scrutiny from lawmakers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.